Clinical Trials Directory

Trials / Unknown

UnknownNCT04909476

Tracheal Intubation in COVID-19 Patients

Airways Management in COVID-19 Related Respiratory Failure: a Prospective Observational Multi-center Study

Status
Unknown
Phase
Study type
Observational
Enrollment
143 (estimated)
Sponsor
St. Bortolo Hospital · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

The Emergency Endotracheal intubation of a patient who is COVID-19 positive is a high-risk procedure and an additional challenge to an intensivist due to barrier enclosures that have been developed to reduce the risk of COVID-19 transmission to healthcare providers during intubation. Although the incidence of difficult airways is commonly higher in critically ill patients, the evidence of severe hypoxemia without sign of respiratory distress could complicate the scenario.This silent hypoxia often leads to a delayed recognition of the severity of respiratory failure and to a late intubation which is often characterized by a high risk of complications related to the actual airways' management, hemodynamic and cardiac. It has been shown that non-survivors had worse blood gas analyzes than survivors, both before and after intubation. Few studies have reported the implications and adverse events of performing endotracheal intubation for critically ill COVID-19 patients admitted to intensive care units (ICUs).

Conditions

Interventions

TypeNameDescription
PROCEDUREEndotracheal intubationAirways management in COVID 19 patients pneumonia

Timeline

Start date
2020-11-17
Primary completion
2021-05-20
Completion
2021-06-10
First posted
2021-06-01
Last updated
2021-06-04

Locations

2 sites across 1 country: Italy

Source: ClinicalTrials.gov record NCT04909476. Inclusion in this directory is not an endorsement.